CD4 receptor-dependent entry of human immunodeficiency virus type-1 env-pseudotypes into CCR5-, CCR3-, and CXCR4-expressing human alveolar macrophages is preferentially mediated by the CCR5 coreceptor

American Journal of Respiratory Cell and Molecular Biology

Volumn 20, Issue 5, 1999, Pages 864-871

  Park, In Woo ^a   Koziel, Henry ^a   Hatch, William ^a   Li, Xiuhong ^a   Du, Bin ^a   Groopman, Jerome E ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

CD4 ANTIGEN; CHEMOKINE RECEPTOR; CHLORAMPHENICOL ACETYLTRANSFERASE; PRIMER DNA;

ADULT; ANIMAL; ARTICLE; CELL LINE; DOG; FEMALE; FLOW CYTOMETRY; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LUNG ALVEOLUS MACROPHAGE; MALE; METABOLISM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; SIMIAN IMMUNODEFICIENCY VIRUS; SPECIES DIFFERENCE; VIROLOGY;

ADULT; ANIMALS; ANTIGENS, CD4; BASE SEQUENCE; CELL LINE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; DNA PRIMERS; DOGS; FEMALE; FLOW CYTOMETRY; HIV-1; HUMANS; MACROPHAGES, ALVEOLAR; MALE; RECEPTORS, CHEMOKINE; SIMIAN IMMUNODEFICIENCY VIRUS; SPECIES SPECIFICITY;

EID: 0033129374     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.20.5.3547     Document Type: Article

References (43)

1. Murray, J., S. Garay, P. Hopewell, J. Mills, G. Snider, and D. Stover. 1987. Pulmonary complications of the acquired immunodeficiency syndrome: an update. Am. Rev. Respir. Dis. 135:504-509.
2. Wallace, J. M., N. I. Hansen, L. Lavange, J. Glassroth, B. L. Browdy, M. J. Rosen, P. A. Kvale, B. T. Mangura, L. B. Reichman, P. C. Hopewell, and the TPCHIS Group, 1997. Respiratory disease trends in the pulmonary complication of HIV infection study cohort. Am. J. Respir. Crit. Care Med 155:72-80.
3. Rose, R. M., A. Krivine, P. Pinkston, J. M. Gillis, A. Huang, and S. M. Hammer. 1991. Frequent identification of HIV-1 DNA in bronchoalveolar lavage cells obtained from individuals with the acquired immunodeficiency syndrome. Am. Res. Respir. Dis. 143:850-854.
4. Sierra-Madero, J., Z. Toossi, D. L. Hom, C. K. Finegan, E. Hoenig, and E. A. Rich. 1994. Relationship between load of virus in alveolar macrophages from human immunodeficiency virus type-1-infected persons, production of cytokines, and clinical status. J. Infect. Dis. 169:18-27.
5. Smith, P. D., K. Ohura, H. Masur, H. C. Lane, A. S. Fauci, and S. M. Wahl. 1984. Monocyte function in the acquired immune deficiency syndrome: defective chemotaxis. J. Clin. Invest. 74:2121-2128.
6. Belsito, D., M. Sanchez, R. Baer, F. Valentine, and G. Thorbecke. 1984. Reduced Langerhans' cell Ia antigen and ATPase activity in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 310:1279-1282.
7. Roy, S., L. Fitz-Gibbon, L. Poulin, and M. Wainberg. 1988. Infection of human monocyte/macrophages by HIV-1: effect on secretion of IL-1 activity. Immunology 64:233-239.
8. Bender, B., M. Frank, T. Lawley, W. Smith, C. Brinkman, and T. Ouinn. 1985. Defective reticuloendothelial system Fc-receptor function in patients with acquired immunodeficiency syndrome. J. Infect. Dis. 152:409-412.
9. Muller, F., H. Rollag, and S. S. Froland. 1990. Reduced oxidative burst responses in monocytes and monocyte-derived macrophages from HIV-infected subjects. Clin. Exp. Immunol. 82:10-15.
10. Denis, M., and E. Ghadirian. 1994. Interaction between Mycobacterium avium and human immunodeficiency virus type I (HIV-1) in bronchoalveolar macrophages of normal and HIV-1-infected subjects. Am. J. Respir. Cell Mol. Biol. 11:487-495.
11. Nakata, K., W. N. Rom, Y. Honda, R. Condos, S. Kanegasaki, Y. Cao, and M. Weiden 1997. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Am. J. Respir. Crit. Care Med. 155:996-1003.
12. Orenstein, J. M., C. Fox, and S. M. Wahl. 1997. Macrophages as a source of HIV during opportunistic infections. Science 276:1857-1861.
13. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC CKR5: A RANTES, MIP-1a, MIP-1B receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955-1958.
14. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di-Marzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666.
15. Dragic, T., V. Litwin, G. P. Allaway, S. R. Martin, Y. Huang, K. A. Nagashima, C. Cayanan, P. J. Maddon, R. A. Koup, J. P. Moore, and W. A. Paxton. 1996. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673.
16. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872-877.
17. Chen, Z., P. Zhou, D. D. Ho, N. R. Landau, and P. A. Marx. 1997. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J. Virol. 71:2705-2714.
18. Furzan, M., H. Choe, K. Martin, L. Marcon, W. Hofmann, G. Karlsson, Y. Sun, P. Barrett, N. Marchand, N. Sullivan, N. Gerard, C. Gerard, and J. Sodroski. 1997. Two orphan seven-transmembrane segment receptors which arc expressed in CD4-positive cells support simian immunodeficiency virus infection. J. Exp. Med. 186:405-411.
19. Kirchhoff, F., S. Pohlmann, M. Harnacher, R. E. Means, T. Kraus, K. Uberla, and P. DiMarzio. 1997. Simian immunodeficiency virus variants with differential T-cell and macrophage tropism use CCR5 and an unidentified cofactor expressed in CEMx174 cells for efficient entry. J. Virol. 71:6509-6516.
20. Zaitseva, M., A. Blauvelt, S. Lee, C. K. Lapham, V. Klaus-Kovtun, H. Moslowski, J. Manischewitz, and H. Golding. 1997. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection. Nat. Med. 3:1369-1375.
21. Moriuchi, H., M. Moriuchi, J. Arthos, J. Hoxie, and A. S. Fauci. 1997. Promonocytic U937 subclones expressing CD4 and CXCR4 are resistant to infection with and cell-to-cell fusion by T-cell-tropic human immunodeficiency virus type 1. J. Virol. 71:9664-9671.
22. Granelli-Piperno, A., B. Moser, M. Pope, D. Chen, Y. Wei, F. Isdell, U. O'Doherty, W. Paxton, R. Koup, S. Mojsov, N. Bhardwaj, I. Clark-Lewis, M. Baggiolini, and R. M. Steinman. 1996. Efficient interaction of HIV-I with purified dendritic cells via multiple chemokine receptors. J. Exp. Med. 184:2433-2438.
23. He, J., Y. Chen, M. Farzan, H. Choe, A. Ohagen, S. Gartner, J. Busciglio, X. Yang, W. Hofmann, W. Newman, C. R. Mackay, J. Sodroski, and D. Gabuzda. 1997. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385:645-649.
24. Wagner, R. P., S. M. Levitz, A. Tabuni, and H. Kornfeld. 1992. HIV-1 envelope protein (gp120) inhibits the activity of human bronchoalveolar macrophages against Cryptococcus neoformans. Am. Rev. Respir. Dis. 146: 1434-1438.
25. Salahuddin, S. Z., R. M. Rose, J. E. Groopman, P. D. Markham, and R. C. Gallo. 1986. Human T lymphotropic virus type III infection of human alveolar macrophages. Blood 68:281-284.
26. Hunninghake, G., J. Gadek, O. Kawanami, V. Ferrans, and R. Crystal. 1979. Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am. J. Pathol. 97: 149-206.
27. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. Mackay, G. LaRosa, W. Newman, N. Gerard, C. Gerard, and J. Sodroski. 1996. The B-chemokine receptors CCR3 and CCR5 facilitate infeclion by primary HIV-1 isolates. Cell 85:1135-1148.
28. Ausubel, F. M., R. Brent, R. E. Kinston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl, editors. 1992. Current Protocols in Molecular Biology, Vol. 2, 2nd ed. John Wiley & Sons, Inc., New York.
29. Davis, G. S., M. S. Giancola, M. C. Costanza, and R. B. Low. 1982. Analysis of sequential bronchoalveolar lavage samples from healthy human volunteers. Am. Rev. Respir. Dis. 126:611-616.
30. Alkhatib, G., F. Liao, E. A. Berger, J. M. Farber, and K. W. C. Peden. 1997. A new SIV co-receptor, STRL33. Nature 388:238. (Letter)
31. Liao, F., G. Alkhatib, K. W. C. Peden, O. Sharma, E. A. Berger, and J. M. Farber, 1997. STRL33 a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J. Exp. Med. 185:2015-2023.
32. Deng, H., D. Unutmaz, V. N. Kewal-Ramani, and D. R. Littman. 1997. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388:296-300.
33. Schuitemaker, H., M. Koot, N. A. Kootstra, M. W. Dereksen, R. E. de Goede, R. P. van Steenwijk, J. M. Lange, J. K. Schattenkerk, F. Miedema, and M. Tersmette. 1992. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J. Virol. 66:1354-1360.
34. Zhang, L. Q., P. MacKenzie, A. Cleland, E. C. Holmes, A. J. Brown, and P. Simmonds. 1993. Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J. Virol. 67:3345-3356.
35. Zhu, T., H. Mo, N. Wang, D. S. Nam, Y. Cao, R. A. Koup, and D. D. Ho. 1993. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 261:1179-1181.
36. Rich, E. A., I. S. Chen, J. A. Zack, M. L. Leonard, and W. A. O'Brien, 1992. Increased susceptibility of differentiated mononuclcar phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J. Clin. Invest. 89:176-183.
37. Meltzer, M. S., D. R. Skillman, P. J. Gomatos, D. C. Kalter, and H. E. Gendelman. 1990. Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection. Annu. Rev. Immunol. 8:169-194.
38. Cameron, M., D. Granger, J. Weinberg, W. Kozumbo, and H. Koren. 1990. Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginate oxidation of nitrite or nitrate, Am. Rev. Respir. Dis. 142:1313-1319.
39. Gauduin, M. C., G. P. Allaway, P. J. Maddon, C. F. Barbas III, D. R. Burton, and R. A. Koup. 1996. Effective ex vivo neutralization of human immunodeficiency virus type 1 in plasma by recombinant immunoglobulin molecules. J. Virol. 70:2586-1592.
40. Cocchi, F., A. L. DeVico, A. Garzino-Demo, S. K. Arya, R. C. Gallo, and P. Lusso. 1995. Identification of RANTES, MIP-1α and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 270:1811-1815.
41. Cocchi, F., A. L. DeVico, A. Garzino-Demo, A. Cara, R. C. Gallo, and P. Lusso. 1996. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nat. Med. 2:1244-1247.
42. Coffey, M. J., C. Woffendin, S. M. Phare, R. M. Strieter, and D. M. Markovitz. 1997. RANTES inhibits HIV-1 replication in human peripheral blood monocytes and alveolar macrophages. Am. J. Physiol. 272:L1025-L1029.
43. Yi, Y., S. Rana, J. D. Turner, N. Gaddis, and R. G. Collman. 1998. CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1. J. Virol. 72:772-777.